Wei Xin
- Molecular Biology top 10%
- Immunology top 5%
- Surgery top 5%
- Epidemiology top 5%
- Oncology top 10%
- Topics
- Hepatitis B Virus Studies (11 papers)Cancer-related molecular mechanisms research (8 papers)Hepatitis C virus research (7 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryAngewandte Chemie International Edition
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wei Xin
133 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 127
- Molecular Biology 1.2k
- Immunology 602
- Surgery 574
- Epidemiology 503
- Oncology 385
Countries citing papers authored by Wei Xin
This map shows the geographic impact of Wei Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xin more than expected).
Fields of papers citing papers by Wei Xin
This network shows the impact of papers produced by Wei Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xin. The network helps show where Wei Xin may publish in the future.
Co-authorship network of co-authors of Wei Xin
This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xin. A scholar is included among the top collaborators of Wei Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xin. Wei Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | miRNA-382-5p Suppresses the Expression of Farnesoid X Receptor to Promote Progression of Liver Cancer | 1 |
| 6 | Cost of Diabetic Foot Ulcer Management in China: A 7-Year Single-Center Retrospective Review | 2 |
| 7 | 49 | |
| 8 | Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder | 1 |
| 9 | 9 | |
| 10 | Long noncoding RNA HCP5 suppresses skin cutaneous melanoma development by regulating RARRES3 gene expression via sponging miR-12 | 1 |
| 11 | Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer | 1 |
| 12 | miR-129-5p inhibits prostate cancer proliferation via targeting ETV1 | 1 |
| 13 | FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer | 1 |
| 14 | 25 | |
| 15 | 39 | |
| 16 | Hyaluronan-modified superparamagnetic iron oxide nanoparticles for bimodal breast cancer imaging and photothermal therapy | 4 |
| 17 | Cytochrome P450 1A1 exon 7 polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review | 1 |
| 18 | 27 | |
| 19 | 28 | |
| 20 | [Sentinel lymph node biopsy in head and neck cancer patients]. | 2 |
About Wei Xin
Wei Xin is a scholar working on Hepatology, Immunology and Cancer Research, having authored 143 papers that have together received 3.1k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (11 papers), Cancer-related molecular mechanisms research (8 papers) and Hepatitis C virus research (7 papers). The work is most often cited by research in Immunology (602 citations), Endocrinology (125 citations) and Cancer Research (308 citations). Wei Xin has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Roy Curtiss, Lan Zhou, Zhiqin Lin, Shifeng Wang, Shuhua Mi, Soo-Young Wanda, Yuhua Li, Bronwyn M. Gunn, Joel K. Greenson and Shuiliang Yu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.